VTRSViatris Inc.

$16B

Q2 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.8B-5.2% YoY

Gross Profit

$963M34.3% margin

Operating Income

$179M6.4% margin

Net Income

$38M1.3% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

$430M

Free Cash Flow

$385M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$33.3B

Total Liabilities

$21.1B

Stockholders' Equity

$12.2B

Cash & Equivalents

$330M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.8B	$3.0B	-5.2%
Gross Profit	$963M	$1.2B	-21.5%
Operating Income	$179M	$474M	-62.2%
Net Income	$38M	$297M	-87.4%

VTRS Q2 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena